138 related articles for article (PubMed ID: 15683666)
1. HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcome.
Shrivastava SK; Engineer R; Rajadhyaksha S; Dinshaw KA
Radiother Oncol; 2005 Jan; 74(1):31-5. PubMed ID: 15683666
[TBL] [Abstract][Full Text] [Related]
2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
3. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
4. Comment on: "HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcome" [Radiother Oncol 2005;74:31-35, Shrivastava et al.].
Selek U; Cengiz M; Ozyigit G; Yildiz F; Lale Atahan I
Radiother Oncol; 2005 Jul; 76(1):107-8; author reply 108. PubMed ID: 15885832
[No Abstract] [Full Text] [Related]
5. Human immunodeficiency virus infection and invasive cervical cancer in South Africa.
Lomalisa P; Smith T; Guidozzi F
Gynecol Oncol; 2000 Jun; 77(3):460-3. PubMed ID: 10831360
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens.
Wang Y; Tsang R; Asa S; Dickson B; Arenovich T; Brierley J
Cancer; 2006 Oct; 107(8):1786-92. PubMed ID: 16967442
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
8. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated radiotherapy in carcinoma cervix IIIB: Tata Memorial Hospital experience.
Muckaden MA; Budrukkar AN; Tongaonkar HB; Dinshaw KA
Indian J Cancer; 2002; 39(4):127-34. PubMed ID: 12928570
[TBL] [Abstract][Full Text] [Related]
10. AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial.
Dobrowsky W; Huigol NG; Jayatilake RS; Kizilbash NI; Okkan S; Kagiya VT; Tatsuzaki H
Radiother Oncol; 2007 Jan; 82(1):24-9. PubMed ID: 17161478
[TBL] [Abstract][Full Text] [Related]
11. HIV impact on acute morbidity and pelvic tumor control following radiotherapy for cervical cancer.
Gichangi P; Bwayo J; Estambale B; Rogo K; Njuguna E; Ojwang S; Temmerman M
Gynecol Oncol; 2006 Feb; 100(2):405-11. PubMed ID: 16274737
[TBL] [Abstract][Full Text] [Related]
12. Radical radiotherapy with high-dose-rate brachytherapy for uterine cervix cancer long-term results.
Khor TH; Tuan JK; Hee SW; Tham IW
Australas Radiol; 2007 Dec; 51(6):570-7. PubMed ID: 17958695
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome for chemoradiotherapy in carcinoma of the cervix.
Spensley S; Hunter RD; Livsey JE; Swindell R; Davidson SE
Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):49-55. PubMed ID: 19081712
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome after radiotherapy for FIGO stage IIIB and IVA carcinoma of the cervix.
Yeung AR; Amdur RJ; Morris CG; Morgan LS; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1445-50. PubMed ID: 17234362
[TBL] [Abstract][Full Text] [Related]
15. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer).
Classe JM; Rauch P; Rodier JF; Morice P; Stoeckle E; Lasry S; Houvenaeghel G;
Gynecol Oncol; 2006 Sep; 102(3):523-9. PubMed ID: 16504274
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma.
Hyun Kim T; Choi J; Park SY; Lee SH; Lee KC; Yang DS; Shin KH; Cho KH; Lim HS; Kim JY
Cancer; 2005 Sep; 104(6):1304-11. PubMed ID: 16078262
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer.
Novetsky AP; Einstein MH; Goldberg GL; Hailpern SM; Landau E; Fields AL; Mutyala S; Kalnicki S; Garg M
Gynecol Oncol; 2007 Jun; 105(3):635-40. PubMed ID: 17331568
[TBL] [Abstract][Full Text] [Related]
18. [Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix].
Ma SK; Wu LY; Sun YC; Li B; Zhang HT
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):13-7. PubMed ID: 18366925
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
Chen MF; Tseng CJ; Tseng CC; Yu CY; Wu CT; Chen WC
Cancer J; 2008; 14(3):200-6. PubMed ID: 18536561
[TBL] [Abstract][Full Text] [Related]
20. Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis.
Hille A; Christiansen H; Pradier O; Hermann RM; Siekmeyer B; Weiss E; Hilgers R; Hess CF; Schmidberger H
Strahlenther Onkol; 2005 Sep; 181(9):606-14. PubMed ID: 16170489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
